Mail

Australia markets closed

ALL ORDS
7,285.10
-12.60(-0.17%)
ASX 200
7,073.20
-14.10(-0.20%)
AUD/USD
0.6677
+0.0067(+1.02%)
OIL
74.38
-1.58(-2.08%)
GOLD
2,091.70
+34.50(+1.68%)
Bitcoin AUD
59,110.91
+899.29(+1.54%)

FEELING THE PINCH?

Beat the cost-of-living squeeze with our pro tips and helpful hacks - sign up now

Antisense Therapeutics Limited (ANP.AX)

ASX - ASX Delayed price. Currency in AUD

Add to watchlist

0.0600

+0.0030

(+5.26%)

At close: 04:10PM AEDT

Currency in AUD

Valuation measures⁴

Market cap (intra-day)	54.09M
Enterprise value	43.27M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	5.42
Enterprise value/revenue	N/A
Enterprise value/EBITDA	-3.27

Trading information

Stock price history

Beta (5Y monthly)	1.23
52-week change ³	-30.23%
S&P500 52-week change ³	14.90%
52-week high ³	0.1100
52-week low ³	0.0500
50-day moving average ³	0.0627
200-day moving average ³	0.0689

Share statistics

Avg vol (3-month) ³	443.01k
Avg vol (10-day) ³	204.46k
Shares outstanding ⁵	901.55M
Implied shares outstanding ⁶	949M
Float ⁸	601.19M
% held by insiders ¹	16.27%
% held by institutions ¹	3.95%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	1:10
Last split date ³	06 Nov 2013

Financial highlights

Fiscal year

Fiscal year ends	30 June 2023
Most-recent quarter (mrq)	30 June 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	-598.13%

Management effectiveness

Return on assets (ttm)	-41.69%
Return on equity (ttm)	-73.14%

Income statement

Revenue (ttm)	1.58M
Revenue per share (ttm)	0.00
Quarterly revenue growth (yoy)	-28.40%
Gross profit (ttm)	1.55M
EBITDA	-11.75M
Net income avi to common (ttm)	-11.38M
Diluted EPS (ttm)	-0.0200
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	10.97M
Total cash per share (mrq)	0.01
Total debt (mrq)	142.1k
Total debt/equity (mrq)	1.42%
Current ratio (mrq)	4.51
Book value per share (mrq)	0.01

Cash flow statement

Operating cash flow (ttm)	-8.15M
Levered free cash flow (ttm)	-4.17M